Mark Hallett Selected Research

Deep Brain Stimulation

2/2024	Persistence of Basal Ganglia Oscillatory Activity During Tremor Attenuation by Movement in Parkinson's Disease Patients.
4/2023	Association of polygenic risk score with response to deep brain stimulation in Parkinson's disease.
2/2023	Subthalamic Oscillatory Activity of Reward and Loss Processing Using the Monetary Incentive Delay Task in Parkinson Disease.
1/2023	Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
1/2022	Discussion of Research Priorities for Gait Disorders in Parkinson's Disease.
12/2020	KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.
1/2019	Effects of deep brain stimulation on the primary motor cortex: Insights from transcranial magnetic stimulation studies.
1/2018	Parkinson's Disease Motor Subtypes Show Different Responses to Long-Term Subthalamic Nucleus Stimulation.
1/2018	Pallidal deep brain stimulation modulates cortical excitability and plasticity.
9/2016	Characteristics of subthalamic oscillatory activity in parkinsonian akinetic-rigid type and mixed type.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Hallett Research Topics

Disease

30	Parkinson Disease (Parkinson's Disease) 05/2024 - 09/2004
28	Tremor (Tremors) 02/2024 - 11/2003
26	Task-Specific Focal Dystonia 01/2023 - 05/2004
21	Dystonia (Limb Dystonia) 09/2023 - 01/2002
17	Essential Tremor (Essential Tremors) 12/2023 - 11/2003
17	Dystonic Disorders (Writer's Cramp) 06/2022 - 01/2002
7	Stroke (Strokes) 04/2010 - 08/2002
6	Movement Disorders (Movement Disorder) 01/2023 - 02/2009
6	Blepharospasm 11/2022 - 04/2013
6	Torticollis (Wryneck) 01/2020 - 06/2013
5	Hypokinesia (Bradykinesia) 01/2020 - 03/2006
4	Tics (Tic) 01/2021 - 06/2012
3	Parkinsonian Disorders (Parkinsonism) 09/2023 - 10/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 09/2008
3	Dyskinesias (Dyskinesia) 01/2023 - 04/2009
3	Nervous System Diseases (Neurological Disorders) 01/2023 - 03/2008
3	Pain (Aches) 09/2015 - 02/2004
2	Fatigue 02/2024 - 01/2024
2	Gaucher Disease (Gaucher's Disease) 09/2023 - 10/2008
2	Cognitive Dysfunction 07/2023 - 07/2008
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 02/2023 - 06/2012
2	Muscle Cramp (Cramp) 01/2023 - 12/2017
2	Seizures (Absence Seizure) 01/2023 - 01/2021
2	Conversion Disorder (Astasia Abasia) 11/2021 - 09/2015
2	Dysphonia (Spastic Dysphonia) 12/2020 - 09/2013
2	Benign essential blepharospasm 05/2018 - 10/2010
2	Migraine Disorders (Migraine) 05/2016 - 09/2015
2	Myoclonus (Nocturnal Myoclonus) 01/2016 - 02/2005
2	Dystonia musculorum deformans type 1 06/2015 - 01/2007
2	Sialorrhea 11/2014 - 06/2013
2	Hemifacial Spasm 11/2013 - 06/2013
2	Gambling (Pathological Gambling) 08/2011 - 05/2011
2	Celiac Disease (Celiac Sprue) 05/2007 - 05/2003
2	Ataxia (Dyssynergia) 04/2004 - 05/2003
1	Pneumonia (Pneumonitis) 05/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024
1	Anosmia 09/2023
1	Genetic Risk Score 04/2023
1	Muscular Diseases (Myopathy) 04/2023
1	Spasm (Spasms) 01/2023
1	Ideomotor Apraxia 04/2022

Drug/Important Bio-Agent (IBA)

18	Botulinum Toxins (Botulinum Toxin)IBA 12/2023 - 12/2003
16	FHDIBA 01/2023 - 05/2004
9	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 09/2004
7	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 07/2008
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
5	Ethanol (Ethyl Alcohol)IBA 12/2023 - 11/2003
5	Therapeutic UsesIBA 07/2023 - 06/2006
5	Type A Botulinum Toxins (Botox)FDA Link 11/2022 - 09/2008
5	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 01/2002
5	salicylhydroxamic acid (SHAM)IBA 02/2020 - 06/2006
5	incobotulinumtoxinA FDA Link 05/2016 - 04/2010
4	octanoic acid (caprylic acid)IBA 01/2018 - 07/2012
4	1-Octanol (1 Octanol)IBA 04/2016 - 10/2011
4	AntibodiesIBA 01/2016 - 05/2003
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2023 - 01/2010
3	AlcoholsIBA 01/2014 - 10/2011
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2024 - 12/2022
2	gadoteridol (Prohance)FDA Link 07/2023 - 12/2022
2	Cholinergic Agents (Cholinergics)IBA 01/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 05/2007
2	PlasticsIBA 01/2020 - 03/2006
2	Dopamine Receptors (Dopamine Receptor)IBA 12/2013 - 01/2007
2	HarmalineIBA 07/2012 - 10/2011
2	Carboxylic AcidsIBA 07/2012 - 10/2011
2	Glutens (Glutelin)IBA 05/2007 - 05/2003
1	Triglycerides (Triacylglycerol)IBA 04/2024
1	catechol (pyrocatechol)IBA 02/2024
1	EnzymesIBA 09/2023
1	Dihydroxyphenylalanine (Dopa)IBA 09/2023
1	myosin-binding protein CIBA 04/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Amantadine (Aman)FDA LinkGeneric 01/2023
1	Propranolol (Inderal)FDA LinkGeneric 01/2023
1	GABA Receptors (GABA Receptor)IBA 01/2023
1	Apomorphine FDA Link 01/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023
1	Clozapine (Clozaril)FDA LinkGeneric 01/2023
1	Monoamine Oxidase (MAO)IBA 01/2023
1	SolutionsIBA 11/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	CreatineIBA 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2022
1	COVID-19 VaccinesIBA 11/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021

Therapy/Procedure

25	Therapeutics 11/2022 - 03/2003
24	Transcranial Magnetic Stimulation 01/2023 - 10/2003
16	Deep Brain Stimulation 02/2024 - 08/2010
9	Injections 12/2023 - 10/2009
6	Activities of Daily Living (ADL) 11/2022 - 09/2011
5	Electrodes (Electrode) 09/2016 - 03/2008
4	Transcranial Direct Current Stimulation 04/2022 - 10/2010
2	Ketogenic Diet 04/2024 - 01/2021
2	Microelectrodes 06/2015 - 11/2004
1	Diskectomy (Discectomy) 05/2024
1	Brain-Computer Interfaces 01/2022